Related Experiment Video
Updated: Jul 3, 2026

06:26
Pre-clinical Model of Cardiac Donation after Circulatory Death
Published on: August 2, 2019
Organ procurement after cardiocirculatory death: a critical analysis
Mohamed Y Rady1, Joseph L Verheijde, Joan McGregor
1Department of Critical Care Medicine, Mayo Clinic Hospital, Phoenix, Arizona 85054, USA. rady.mohamed@mayo.edu
Journal of Intensive Care Medicine
|July 24, 2008
Summary
Organ donation after cardiac death (DCD) policies aim to reduce transplant wait times but raise ethical concerns. The study questions the validity of DCD protocols and their impact on end-of-life care and patient outcomes.
Area of Science:
- Medical Ethics
- Transplantation Medicine
- Public Health Policy
Background:
- Federal regulations mandate organ donation after cardiac (or circulatory) death (DCD) policies to decrease transplant waiting times in the U.S.
- The University of Pittsburgh Medical Center (UPMC) protocol and University of Wisconsin (UW) evaluation tool are central to current DCD practices.
- Existing evidence is insufficient to confirm UPMC protocol criteria align with the dead donor rule.
Purpose of the Study:
- To evaluate the ethical implications and practical challenges of organ donation after cardiac death (DCD) in the United States.
- To assess the accuracy of the University of Wisconsin (UW) evaluation tool in identifying organ donors.
- To examine the potential conflicts between end-of-life care for donors and organ procurement requirements.
Main Methods:
- Review of existing evidence on DCD protocols, specifically the UPMC protocol and UW evaluation tool.
- Analysis of potential conflicts between perimortem interventions for organ preservation and quality end-of-life care.
- Examination of recipient outcomes associated with organs recovered from DCD donors.
Main Results:
- The validity of UPMC protocol criteria regarding the dead donor rule lacks substantial evidence.
- A high false-positive rate for the UW tool may lead to unnecessary interventions for potential donors.
- Interventions to preserve organs can negatively impact the quality of end-of-life care for donors.
- Recipients of marginal DCD organs face increased mortality and morbidity risks.
Conclusions:
- There is a critical need to reconcile end-of-life care with organ procurement from terminally ill patients undergoing DCD.
- The accuracy and ethical implications of DCD protocols, including the UW tool, require further investigation.
- Transparent public disclosure regarding DCD risks is essential for informed societal debate on its ethical acceptability.

